|
| |
|
WEDNESDAY,
MARCH 28, 2001
|
07:00-08:30
 |
M3
Meet The Expert Session III
INFECTIONS CAUSED BY HERPESVIRUSES IN NEONATES
S. Kohl*, USA
|
HALL
C |
| 07:00-08:30 |
M4
Meet The Expert Session IV
ANTIBIOTIC RESISTANCE
K.P. Klugman*, USA
|
HALL
D |
| 08:45-10:45 |
PL2
PLENARY SESSION II
Chairpersons: A.
Finn, UK
I. Shalit, Israel |
HALL
A |
| 08:45 |
USE
OF SURROGATE MARKERS OF IMMUNITY FOR IMPLEMENTATION OF NEW VACCINE
STRATEGIES
C.A. Siegrist*, Switzerland |
|
| 09:15 |
THE
CHALLENGE OF BACTERIAL ENTERIC INFECTIONS
S. Ashkenazi*, Israel |
|
| 09:45 |
ROTAVIRUS
VACCINES: WHAT HAVE WE LEARNED AND WHERE ARE WE GOING?
R. Glass*, USA |
|
| 10:15 |
ADULT
AND CHILDHOOD VACCINATION: TWO SIDES OF THE SAME COIN
D.S. Fedson*, France |
|
| 10:45 |
Coffee
Break and Poster Visit |
|
| 12:00-13:00 |
EM
ANNUAL ESPID MEETING |
HALL
A |
| 13:00 |
Lunch
Break |
|
| 14:00-15:15 |
S6
SUCCESSFUL TREATMENT OF COMMUNITY-ACQUIRED RTIs: PROGRESSING ALONG THE
LEARNING CURVE
Symposium sponsored by: GLAXOSMITHKLINE PHARMA
Chairperson: K.P.
Klugman, USA |
HALL
A |
| 14:00 |
RESISTANCE
- A BIG PROBLEM IN LITTLE CHILDREN
K.P. Klugman*, USA |
|
| 14:15 |
PK/PD
PRINCIPLES - ENHANCED UNDERSTANDING FOR ENHANCED ANTIBIOTIC PRESCRIBING
M. Jacobs*, USA |
|
| 14:35 |
THE
IMPACT OF RESISTANCE ON CLINICAL OUTCOME - LEARNING FROM EXPERIENCE
R. Dagan*, Israel |
|
| 14:55 |
APPROPRIATE
ANTIBIOTIC PRESCRIBING - WHAT LESSONS HAVE WE LEARNT?
K.P. Klugman*, USA |
|
| 15:15 |
Coffee
Break and Exhibition Visit |
|
| 15:45-17:45 |
O3
ORAL & SELECTED POSTER PRESENTATIONS III
Chairpersons: U.
Heininger, Switzerland
I. Ildirim, Turkey |
HALL
A |
| 15:45 |
INDUCTION
OF HERD IMMUNITY AGAINST PERTUSSIS WITH A MONOCOMPONENT PERTUSSIS TOXOID
VACCINE
B. Trollfors*, J. Taranger, E. Bergfors, N. Knutsson, V. Sundh, T.
Lagergard, Sweden |
|
| 16:00 |
PERTUSSIS
IS UNDER-ESTIMATED IN INFANTS ADMITTED TO PAEDIATRIC INTENSIVE CARE UNITS
AND WARDS IN LONDON
N.S. Crowcroft*, L. Spicer, O. Tzivra, N. Fry, T. Harrison, C. Maple, Q.
Mok, J. Britto, A. French, R. Booy, E.
Miller, UK |
|
| 16:15 |
EVIDENCE
FOR PRE-BOOSTER ANTIBODY PERSISTENCE IN AN OPEN RANDOMIZED STUDY ON
INFANTS PRIMED WITH DTPa-HBV-IPV/Hib OR DTPa-IPV/Hib + HBV VACCINES AT 3,
4, 5 MONTHS OF AGE
U. Heininger*, L. Schuerman, Switzerland |
|
| 16:30 |
ANTIBODY
AVIDITY AND IGG ISOTYPE DISTRIBUTION FOLLOWING IMMUNISATION WITH A
MONOVALENT MENINGOCOCCAL B OUTER MEMBRANE VESICLE (OMV) VACCINE
C.L. Vermont*, H. Van Dijken, R. De Groot, G. Van Den Dobbelsteen, The
Netherlands |
|
| 16:45 |
A
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY
OF ORAL HUMAN LIVE ATTENUATED ROTAVIRUS VACCINE 89-12 IN HEALTHY INFANTS:
EXTENSION OF
THE SURVEILLANCE PERIOD TO INCLUDE A SECOND ROTAVIRUS SEASON
D. Bernstein*, D.A. Sack, K. Reisinger, E. Rothstein, R. Ward, B. De Vos,
USA |
|
|
SELECTED
POSTERS FOR ORAL PRESENTATION
|
| 17:00 |
EVALUATION
OF CELLULAR AND HUMORAL IMMUNE RESPONSE FOLLOWING INFECTION OR VACCINATION
IN CHILDREN WITH MALIGNANCY AFTER COMPLETION OF CHEMOTHERAPY
A. Russo*, J. Faber, P. Habermehl, M. Dittrich, D. Klotz, M. Knuf, C.
Meyer, H.J. Schmitt, F. Zepp, Germany |
|
| 17:15 |
RISK
OF DEMYELINATING DISEASE AFTER HEPATITIS B VACCINATION
T.M. Verstraeten*, F. Destefano, L. Jackson, P. Benson, C. Okoro, S.
Black, H. Shinefield, J. Mullooly, R.
Chen, USA |
|
| 17:22 |
LONG-TERM
FOLLOW-UP OF CHILDREN WITH HYPOTONIC HYPORESPONSIVE EPISODES (HHE)
H. Heijbel*, K. Stjernquist, L. Gustafsson, G. Wrahme Hellstrom, P. Olin,
Sweden |
|
| 17:29 |
A
BOOSTER STUDY OF TDCP+IPV, TDCP-IPV, OR DT+IPV AT 5 1/2 YEARS OF AGE AFTER
PRIMARY IMMUNISATION WITH DTCP AT 3, 5, 12 MONTHS OF AGE
P. Olin*, L. Gustafsson, H.O. Hallander, E. Netterlid, E. Reizenstein,
Sweden |
|
| 17:36 |
BCG,
TUBERCULIN SKIN-TEST RESULTS AND ASTHMA PREVALENCE IN SCHOOLCHILDREN IN
NORTH LONDON
A. Pahari*, S. Welch, S. Lingam, UK |
|
| 15:45-17:45 |
O4
ORAL & SELECTED POSTER PRESENTATIONS IV
Chairpersons: F.
Asensi-Botet, Spain
D. Engelhard, Israel |
HALL
B |
| 15:45 |
EPIDEMIOLOGY
OF INFANTILE MENINGITIS - RESULTS FROM A FIVE-YEAR PROSPECTIVE FOLLOW-UP
OF 1721 SURVIVORS OF MENINGITIS IN THE FIRST YEAR OF LIFE
J. De Louvois*, H. Bedford, C. Peckham, D. Harvey, UK |
|
| 16:00 |
RISK
FACTORS FOR SEQUELAE IN SCHOOL-AGE SURVIVORS OF BACTERIAL MENINGITIS
I. Koomen*, H.D.W. Van Der Lei, D.E. Grobbee, J.J. Roord, A.
Jennekens-Schinkel, A.M. Van Furth, The
Netherlands |
|
| 16:15 |
NECROTIZING
PNEUMONIA DUE TO STAPHYLOCOCCUS AUREUS STRAINS PRODUCING THE PANTON
VALENTINE LEUCOTOXIN
I. Bertrand, V. Philippe, J.C. Fournet, M. Bes, G. Lina, F. Vandenesch, Y.
Piemont, N. Brousse, D. Floret, J.
Etienne, Y. Gillet*, France |
|
| 16:30 |
IMMUNOLOGICAL
EVALUATION OF CHILDREN WITH RECURRENT ACUTE OTITIS MEDIA
R.H. Veenhoven*, A.G.M. Schilder, C.T. Rijkers, C.S.P.M. Uiterwaal, W.
Kuis, E.A.M. Sanders, The
Netherlands |
|
| 16:45 |
RHINOVIRUS
INDUCED WHEEZING IN INFANCY CARRIES A RISK FOR ASTHMA
A. Kotaniemi-Syrjanen, R. Vanionpaa, T. Reijonen, M. Korppi*, Finland |
|
| 17:00 |
TICK-BORNE
ENCEPHALITIS (TBE) IN CHILDREN FROM 1980 THROUGH 1999 IN STYRIA/AUSTRIA
W. Zenz*, H. Pansi, I. Mutz, M. Cizman, A. Kraigher, A. Berghold, D. Spork,
Austria |
|
|
SELECTED
POSTERS FOR ORAL PRESENTATION
|
| 17:15 |
MOLECULAR
DIAGNOSIS OF MEDITERRANEAN SPOTTED FEVER BY POLYMERASE CHAIN REACTION
D. Wachtel*, Y. Schlesinger, D. Halle, B. Rudensky, A. Liddell, T. Wilson,
Israel |
|
| 17:22 |
COMPARISON
OF RSV DETECTION BY RSV-ANTIGEN-ELISA AND MULTIPLEX PCR IN LOWER
RESPIRATORY TRACT INFECTIONS IN CHILDREN
J. Bittscheidt*, A. Rohwedder, J. Schwarze, J. Forster, G. Petersen, H.
Werchau, V. Stephan, Germany |
|
| 17:29 |
DEVELOPMENT
OF A TYPE-SPECIFIC MULTIPLEX PCR FOR STREPTOCOCCUS PNEUMONIAE
A. Saukkoriipi*, D.C. Miller, L. Kuisma, M. Leinonen, J.C. Paton, Finland |
|
| 17:36 |
POST-CIRCUMCISION
URINARY TRACT INFECTION IN NEONATES
L. Harel*, R. Straussberg, J. Amir, Israel |
|
top of page
|
